{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:58:38Z","timestamp":1774713518567,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000028","name":"CIHR ICRH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["185469"],"award-info":[{"award-number":["185469"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cjca.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:39:16Z","timestamp":1763771956000},"page":"575-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working Group"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-0021","authenticated-orcid":false,"given":"Benjamin T.","family":"Leis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahee","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piroze M.","family":"Davierwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Brothers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landon \u201cMorty\u201d","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Fairgrieve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena A.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay S.","family":"Shavadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Uzair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansar","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil P.","family":"Fam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Caudarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.11.009_bib1","first-page":"775","article-title":"Dealing with the epidemic of endocarditis in people who inject drugs","volume":"38","author":"Vervoort","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/ADM.0000000000000928","article-title":"Trends in hospitalizations for serious infections among people with opioid use disorder in Ontario, Canada","volume":"16","author":"Gomes","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012465","article-title":"Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005-2014","volume":"9","author":"Mori","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.11.009_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cjco.2020.05.002","article-title":"Epidemiology, microbiology, and clinical outcomes among patients with intravenous drug use-associated infective endocarditis in New Brunswick","volume":"2","author":"Mosseler","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/CXA.0000000000000053","article-title":"Rates of infective endocarditis in substance use disorder and associated costs in Ontario","volume":"10","author":"Coverdale","year":"2019","journal-title":"Can J Addict"},{"key":"10.1016\/j.cjca.2025.11.009_bib6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjco.2021.07.014","article-title":"The epidemiology of endocarditis in Manitoba: a retrospective study","volume":"3","author":"Maguire","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib7","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1503\/cmaj.180694","article-title":"The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis","volume":"191","author":"Weir","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2025.11.009_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12954-021-00492-6","article-title":"Hospital admissions and mortality due to complications of injection drug use in two hospitals in Regina, Canada: retrospective chart review","volume":"18","author":"Tsybina","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cjca.2025.11.009_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis---Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence---North Carolina, 2010-2015","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cjca.2025.11.009_bib12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.athoracsur.2020.12.003","article-title":"Infective endocarditis secondary to injection drug use: a survey of Canadian cardiac surgeons","volume":"112","author":"An","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.athoracsur.2020.05.133","article-title":"Knowledge and attitudes of Canadian cardiac surgeons regarding patients with human immunodeficiency virus","volume":"111","author":"Bami","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/HCO.0000000000000493","article-title":"Endocarditis in the setting of IDU: multidisciplinary management","volume":"33","author":"Yanagawa","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib15","first-page":"1689","article-title":"Cardiac surgery in HIV patients: state of the art","volume":"34","author":"Yanagawa","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2022.03.349","article-title":"Diagnosis and management of infective endocarditis in people who inject drugs: JACC state-of-the-art review","volume":"79","author":"Yucel","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cjco.2021.02.015","article-title":"Injection drug use endocarditis: an inner-city hospital experience","volume":"3","author":"Syed","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib18","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/add.16257","article-title":"Social and structural determinants of injection drug use-associated bacterial and fungal infections: a qualitative systematic review and thematic synthesis","volume":"118","author":"Brothers","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.cjca.2025.11.009_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12954-020-00378-z","article-title":"Risk factors of infective endocarditis in persons who inject drugs","volume":"17","author":"Shah","year":"2020","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cjca.2025.11.009_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jacc.2023.12.016","article-title":"Infective endocarditis in patients addicted to injected opioid drugs","volume":"83","author":"Javorski","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104218","article-title":"Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: a self-controlled case series in New South Wales, Australia","volume":"122","author":"Brothers","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"suppl","key":"10.1016\/j.cjca.2025.11.009_bib23","article-title":"Multi-Disciplinary Clinical Endocarditis Pathway (MENDO): community as cure","volume":"40","author":"Yee","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101353","article-title":"AngioVac for vegetation debulking in right-sided infective endocarditis: a systematic review and meta-analysis","volume":"47","author":"Mhanna","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/aca.aca_156_21","article-title":"AngioVac system for infective endocarditis: a new treatment for an old disease","volume":"26","author":"Poliwoda","year":"2023","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.cjca.2025.11.009_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.athoracsur.2020.08.036","article-title":"Percutaneous mechanical aspiration vs valve surgery for tricuspid valve endocarditis in people who inject drugs","volume":"111","author":"Veve","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjmed.2024.04.031","article-title":"Comparison of medical therapy, valve surgery, and percutaneous mechanical aspiration for tricuspid valve infective endocarditis","volume":"137","author":"El-Dalati","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s11606-010-1371-4","article-title":"Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission","volume":"25","author":"Glasgow","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/1472-6963-13-415","article-title":"A population-based analysis of leaving the hospital against medical advice: incidence and associated variables","volume":"13","author":"Kraut","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cjca.2025.11.009_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.7326\/M22-2964","article-title":"Retiring the \"against medical advice\" discharge","volume":"175","author":"Kleinman","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib31","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.11.009_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075194","article-title":"Understanding the impact of a residential housing program for people living with HIV\/AIDS: results from a realist evaluation","volume":"14","author":"Ali","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae613","article-title":"Management of people who inject drugs with serious injection-related infections in an outpatient setting: a scoping review","volume":"11","author":"Dalai","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib34","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1093\/eurheartj\/ehad715","article-title":"Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study","volume":"44","author":"Pries-Heje","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.11.009_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciad119","article-title":"Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study","volume":"77","author":"Freling","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263156","article-title":"Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis","volume":"17","author":"Brothers","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2025.11.009_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2018.03.001","article-title":"Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems","volume":"102","author":"Weinstein","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cjca.2025.11.009_bib39","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","article-title":"Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association","volume":"146","author":"Baddour","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.athoracsur.2021.02.027","article-title":"The clinical impact of implementation of a multidisciplinary endocarditis team","volume":"113","author":"El-Dalati","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.21037\/acs.2019.09.03","article-title":"The value of an \u201cendocarditis team.\u201d","volume":"8","author":"Davierwala","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.medmal.2018.06.007","article-title":"Management of infective endocarditis and multidisciplinary approach","volume":"49","author":"Camou","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cjca.2025.11.009_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtcvs.2021.10.048","article-title":"Multidisciplinary team approach to confront the challenge of drug use\u2013associated infective endocarditis","volume":"166","author":"Paras","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib45","series-title":"Choc Septique: D\u00e9faillance Myocardique et Alt\u00e9rations des Relations Force-Fr\u00e9quence et Relaxation-Fr\u00e9quence","author":"Joulin","year":"2009"},{"key":"10.1016\/j.cjca.2025.11.009_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2110-5820-1-6","article-title":"Septic cardiomyopathy","volume":"1","author":"Vieillard-Baron","year":"2011","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.cjca.2025.11.009_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.echo.2012.02.009","article-title":"Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support","volume":"25","author":"Aissaoui","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2025.11.009_bib48","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1161\/CIRCULATIONAHA.105.579268","article-title":"A clinician's guide to tissue Doppler imaging","volume":"113","author":"Ho","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1109\/58.935730","article-title":"Strain rate imaging using two-dimensional speckle tracking","volume":"48","author":"Kaluzynski","year":"2001","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"key":"10.1016\/j.cjca.2025.11.009_bib50","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/CCM.0b013e318174db05","article-title":"Actual incidence of global left ventricular hypokinesia in adult septic shock","volume":"36","author":"Vieillard-Baron","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","article-title":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials","volume":"30","author":"Zangrillo","year":"2015","journal-title":"J Crit Care"},{"key":"10.1016\/j.cjca.2025.11.009_bib53","first-page":"1346","article-title":"Levosimendan in the treatment of patients with severe septic cardiomyopathy","volume":"13","author":"Tsolaki","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.cjca.2025.11.009_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.jvca.2022.10.032","article-title":"Efficacy of levosimendan in the treatment of patients with severe septic cardiomyopathy","volume":"37","author":"Sun","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cjca.2025.11.009_bib55","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib56","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00134-019-05731-w","article-title":"Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial","volume":"45","author":"Antcliffe","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00392-014-0722-2","article-title":"Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome","volume":"103","author":"De Santis","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0000000000000992","article-title":"Reducing elevated heart rates in patients with multiple organ dysfunction syndrome with the if (funny channel current) inhibitor ivabradine","volume":"49","author":"Nuding","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.cjca.2025.11.009_bib59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(20)30733-9","article-title":"Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study","volume":"396","author":"Br\u00e9chot","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.11.009_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad052","article-title":"Epidemiology and clinical outcomes of non-HACEK gram-negative infective endocarditis","volume":"10","author":"Shah","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf036","article-title":"Emergence of infective endocarditis due to Serratia spp.: results of a multicenter cohort","volume":"12","author":"McCrary","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib62","article-title":"Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections","volume":"9","author":"Fanucchi","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib63","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.3390\/jcm13154319","article-title":"Intraoperative polymerase chain reaction from cardiac valve tissue is beneficial for guiding further therapy in patients with infective endocarditis","volume":"13","author":"von Zeppelin","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ejcts\/ezy325","article-title":"Impact of the duration of antibiotic therapy on relapse and survival following surgery for active infective endocarditis","volume":"55","author":"Rao","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2020.0555","article-title":"Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review","volume":"180","author":"Spellberg","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac706","article-title":"Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV","volume":"10","author":"Davar","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib67","first-page":"253","article-title":"Partial oral versus full intravenous antibiotic treatment of endocarditis in people who inject drugs: a systematic review","volume":"8","author":"Brown","year":"2024","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"10.1016\/j.cjca.2025.11.009_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26366","article-title":"Guidelines for diagnosis and management of infective endocarditis in adults: a WikiGuidelines Group Consensus Statement","volume":"6","author":"McDonald","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac008","article-title":"Partial oral antibiotic treatment of endocarditis in patients who inject drugs: a case series","volume":"4","author":"Miller","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cjca.2025.11.009_bib70","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0541","article-title":"Simulated cost-effectiveness and long-term clinical outcomes of addiction care and antibiotic therapy strategies for patients with injection drug use-associated infective endocarditis","volume":"5","author":"Adams","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib71","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciac714","article-title":"Outcomes of partial oral antibiotic treatment for complicated Staphylococcus aureus bacteremia in people who inject drugs","volume":"76","author":"Wildenthal","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy026","article-title":"Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections","volume":"5","author":"Burnham","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib74","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/jac\/dkae211","article-title":"Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study","volume":"79","author":"Ong","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cjca.2025.11.009_bib75","article-title":"In plain sight: the need for a dedicated cardiovascular infectious disease subspecialty","volume":"3","author":"El-Dalati","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.cjca.2025.11.009_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae166","article-title":"Shared decision-making for partial oral antibiotic treatment of infective endocarditis: a case series","volume":"11","author":"El-Dalati","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s15010-024-02393-9","article-title":"A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis","volume":"53","author":"Leanza","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.cjca.2025.11.009_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae186","article-title":"Real-world dalbavancin use for serious gram-positive infections: comparing outcomes between people who use and do not use drugs","volume":"11","author":"Zambrano","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib79","doi-asserted-by":"crossref","unstructured":"Turner NA, Hamasaki T, Doernberg SB, et al. Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial [e-pub ahead of print]. JAMA. doi:10.1001\/jama.2025.12543.","DOI":"10.1001\/jama.2025.12543"},{"key":"10.1016\/j.cjca.2025.11.009_bib80","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1093\/cid\/ciad664","article-title":"Frame shift: Focusing on harm reduction and shared decision making for people who use drugs hospitalized with infections","volume":"78","author":"Thakarar","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131638","article-title":"Beyond a team: the comprehensive interdisciplinary endocarditis program in the United States","volume":"397","author":"El-Dalati","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/ADM.0000000000000916","article-title":"The need for multidisciplinary hospital teams for injection drug use-related infective endocarditis","volume":"16","author":"Weimer","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad444","article-title":"Multidisciplinary teams for the management of infective endocarditis: a systematic review and meta-analysis","volume":"10","author":"Roy","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib84","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.psym.2020.06.019","article-title":"Addiction management in hospitalized patients with intravenous drug use\u2013associated infective endocarditis","volume":"61","author":"Ray","year":"2020","journal-title":"Psychosomatics"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2025.11.009_bib85","article-title":"P-930. Infective endocarditis and the role of oral pathogens","volume":"12","author":"Lauriente","year":"2025","journal-title":"Open Forum Infectious Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib86","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/add.15360","article-title":"Illicit drug use and oral health","volume":"116","author":"Rossow","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.cjca.2025.11.009_bib87","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCULATIONAHA.119.040228","article-title":"Multimodality imaging in infective endocarditis: an imaging team within the endocarditis team","volume":"140","author":"Erba","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib88","series-title":"Substance use health competencies for all prescribers---publicly available specification","author":"Hernandez-Basurto","year":"2024"},{"key":"10.1016\/j.cjca.2025.11.009_bib89","article-title":"A step-by-step guide to implementing a multidisciplinary endocarditis team","volume":"8","author":"El-Dalati","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib90","article-title":"Percutaneous mechanical aspiration in infective endocarditis: applications, technical considerations, and future directions","volume":"3","author":"El Sabbagh","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.cjca.2025.11.009_bib91","doi-asserted-by":"crossref","first-page":"630","DOI":"10.21037\/acs.2019.10.05","article-title":"Current AATS guidelines on surgical treatment of infective endocarditis","volume":"8","author":"Pettersson","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.01.103","article-title":"Frailty as a risk predictor in cardiac surgery: beyond the eyeball test","author":"Yanagawa","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib93","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCULATIONAHA.114.013872","article-title":"The new strategy in infective endocarditis: early surgery based on early diagnosis: are we too late when early surgery is best?","volume":"131","author":"Erbel","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib94","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCULATIONAHA.108.773598","article-title":"Surgery for infective endocarditis: who and when?","volume":"121","author":"Prendergast","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib95","first-page":"1283","article-title":"Early vs late surgery for patients with endocarditis and neurological injury: a systematic review and meta-analysis","volume":"34","author":"Tam","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012447","article-title":"Early versus delayed stroke after cardiac surgery: a systematic review and meta-analysis","volume":"8","author":"Gaudino","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.11.009_bib97","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.11.009_bib99","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.athoracsur.2018.04.012","article-title":"Surgical management of tricuspid valve infective endocarditis: a systematic review and meta-analysis","volume":"106","author":"Yanagawa","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/HCO.0000000000000377","article-title":"Innovations in tricuspid valve intervention","volume":"32","author":"El-Eshmawi","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib101","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad344","article-title":"Prophylactic epicardial pacemaker implantation in tricuspid valve replacement","volume":"64","author":"Bazire","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib102","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10840-022-01457-w","article-title":"Timing and mid-term outcomes of using leadless pacemakers as replacement for infected cardiac implantable electronic devices","volume":"66","author":"Breeman","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib103","article-title":"Comparison of safety of leadless pacemakers and transvenous pacemakers: a meta-analysis","volume":"15","author":"Gangannapalle","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cjca.2025.11.009_bib104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ejcts\/ezt226","article-title":"Double valve replacement and reconstruction of the intervalvular fibrous body in patients with active infective endocarditis","volume":"45","author":"Davierwala","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.cjca.2025.11.009_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/imi.0000000000000510","article-title":"Homograft versus conventional prosthesis for surgical management of aortic valve infective endocarditis: a systematic review and meta-analysis","volume":"13","author":"Yanagawa","year":"2018","journal-title":"Innovations (Phila)"},{"key":"10.1016\/j.cjca.2025.11.009_bib106","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ejcts\/ezt206","article-title":"The Ross procedure in endocarditis: a report of 28 cases","volume":"45","author":"Le Guillou","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib107","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad208","article-title":"Mid-term outcomes following the hemi-commando procedure for complex infective endocarditis involving the aortomitral junction","volume":"64","author":"Marin-Cuartas","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.11.009_bib108","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/CIRCULATIONAHA.116.024156","article-title":"Surgical management of infective endocarditis complicated by embolic stroke: practical recommendations for clinicians","volume":"134","author":"Yanagawa","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.11.009_bib109","series-title":"The unique contexts of substance use health: key considerations","author":"Berg","year":"2024"},{"key":"10.1016\/j.cjca.2025.11.009_bib110","doi-asserted-by":"crossref","first-page":"E1280","DOI":"10.1503\/cmaj.241173","article-title":"Management of opioid use disorder: 2024 update to the national clinical practice guideline","volume":"196","author":"Yakovenko","year":"2024","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2025.11.009_bib111","doi-asserted-by":"crossref","first-page":"e2016228","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2025.11.009_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: a systematic review of reviews","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2025.11.009_bib113","first-page":"1","article-title":"The ASAM\/AAAP clinical practice guideline on the management of stimulant use disorder","volume":"18","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib114","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/ADM.0000000000001110","article-title":"A mixed-methods evaluation of an addiction\/cardiology pilot clinic with contingency management for patients with stimulant-associated cardiomyopathy","volume":"17","author":"Leyde","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ADM.0000000000001183","article-title":"Adapting contingency management for hospitalized patients with stimulant use disorder","volume":"17","author":"Peng","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.cjca.2025.11.009_bib116","series-title":"A starting place: understanding systematic stigma barriers to knowledge about substance use health and associated services in Canada","author":"Peters","year":"2024"},{"key":"10.1016\/j.cjca.2025.11.009_bib117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2006.11.013","article-title":"Co-occurring disorders in substance abuse treatment: issues and prospects","volume":"34","author":"Flynn","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.cjca.2025.11.009_bib118","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1360-0443.2010.02902.x","article-title":"Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey","volume":"105","author":"Swendsen","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.cjca.2025.11.009_bib119","doi-asserted-by":"crossref","DOI":"10.1177\/2150132720910289","article-title":"Homeless patients associate clinician bias with suboptimal care for mental illness, addictions, and chronic pain","volume":"11","author":"Gilmer","year":"2020","journal-title":"J Primary Care Commun Health"},{"key":"10.1016\/j.cjca.2025.11.009_bib120","doi-asserted-by":"crossref","first-page":"E1350","DOI":"10.1503\/cmaj.171002","article-title":"Need for equity in treatment of substance use among Indigenous people in Canada","volume":"189","author":"Urbanoski","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2025.11.009_bib121","doi-asserted-by":"crossref","first-page":"594","DOI":"10.46747\/cfp.6909594","article-title":"Racism as a determinant of health and health care","volume":"69","author":"Ramsoondar","year":"2023","journal-title":"Can Family Physician"},{"key":"10.1016\/j.cjca.2025.11.009_bib122","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/ijerph18062993","article-title":"Implementing antiracism interventions in healthcare settings: a scoping review","volume":"18","author":"Hassen","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cjca.2025.11.009_bib123","doi-asserted-by":"crossref","unstructured":"Brothers TD, Lewer D, Bonn M, et al. Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis [e-pub ahead of print]. medRxiv. doi:10.1101\/2024.09.20.24313898.","DOI":"10.1101\/2024.09.20.24313898"},{"key":"10.1016\/j.cjca.2025.11.009_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1425514","article-title":"Evaluation of the outcomes of equity-deserving individuals receiving services and support from integrated substance use health and mental health services: a pilot study protocol","volume":"15","author":"Edalati","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cjca.2025.11.009_bib125","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab631","article-title":"Six moments of infection prevention in injection drug use: an educational toolkit for clinicians","volume":"9","author":"Harvey","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/CXA.0000000000000080","article-title":"Harm reduction for injection drug users with infective endocarditis: a systematic review","volume":"11","author":"Bahji","year":"2020","journal-title":"Can J Addict"},{"key":"10.1016\/j.cjca.2025.11.009_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2024-002908","article-title":"Increasing take-home naloxone kit distribution to patients with substance use disorder before hospital discharge: a quality improvement project","volume":"14","author":"Wong","year":"2025","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.cjca.2025.11.009_bib128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12954-021-00467-7","article-title":"Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization","volume":"18","author":"Lennox","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cjca.2025.11.009_bib129","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.11.009_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256839","article-title":"The Second Heart program---a multidisciplinary team supporting people who inject drugs with infective endocarditis: protocol of a feasibility study","volume":"16","author":"Lennox","year":"2021","journal-title":"PLoS One"},{"issue":"suppl","key":"10.1016\/j.cjca.2025.11.009_bib131","article-title":"The Second Heart program: a peer-focused, multidisciplinary harm reduction intervention to improve outcomes for people who inject drugs after admission for infective endocarditis","volume":"40","author":"Atri","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.11.009_bib132","series-title":"The Bridge outreach infectious diseases clinic: a quality improvement community partnership initiative in Halifax, Nova Scotia","author":"Hughes","year":"2025"},{"key":"10.1016\/j.cjca.2025.11.009_bib133","first-page":"117","article-title":"Why does infective endocarditis from injection drug use bite the tricuspid valve?","volume":"287","author":"Yanagawa","year":"2019","journal-title":"Int J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25013960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25013960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:30:59Z","timestamp":1774711859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25013960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0828282X25013960"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.11.009","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working Group","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}